Virax Biolabs
VRAX
VRAX
4 hedge funds and large institutions have $22.8K invested in Virax Biolabs in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 4 closing their positions.
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$10K |
| 2 |
2
Millennium Management
New York
|
$4.9K |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$780 |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $10K | 24,600 | +24,600 | New |
|
|
TSS
2
Two Sigma Securities
New York
| $7.08K | 18,162 | -6,623 | -27% |
|
|
3
Millennium Management
New York
| $4.9K | 12,576 | +12,576 | New |
|
|
4
Wells Fargo
San Francisco,
California
| $780 | 2,000 | +2,000 | New |
|
|
AC
5
Armistice Capital
New York
| – | – | -1,500,000 | Closed |
|
6
Legal & General Group
London,
United Kingdom
| – | – | -99,763 | Closed |
|
|
HF
7
HRT Financial
New York
| – | – | -15,623 | Closed |
|
8
UBS Group
Zurich,
Switzerland
| – | – | -3,071 | Closed |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|